NCT03561649View on ClinicalTrials.gov

Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 14, 2018

Primary Completion Date

December 14, 2019

Study Completion Date

May 7, 2020

Conditions
Spondylitis, Ankylosing
Interventions
DRUG

Adalimumab

This trial will be conducted by rheumatologists who can follow patients with SpA and conduct this trial in good conditions and in accordance with regulatory and legal recommendations.

Trial Locations (5)

25030

CHU de Besançon, Besançon

38434

CHU de Grenoble, Échirolles

42055

CHU de Saint-Etienne, Saint-Etienne

63003

CHRU de Clermont-Ferrand, Clermont-Ferrand

90016

CH de Belfort, Belfort

All Listed Sponsors
collaborator

SINNOVIAL

UNKNOWN

lead

University Hospital, Grenoble

OTHER

NCT03561649 - Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA | Biotech Hunter | Biotech Hunter